Femasys appoints John Canning as COO [Seeking Alpha]
Femasys Inc. (FEMY)
Company Research
Source: Seeking Alpha
Canning had brought over 25 years of medical device experience, including prior roles as COO and CTO at Terumo Aortic, where he led global operations, advanced product pipelines, and played a key role in the acquisition of Bolton Medical. The company had granted Canning an option to purchase 0.15M shares at an exercise price equal to its stock's closing price on the grant date. Shares +5.93%. Fresh Stock Ideas, Every Day More on Femasys Femasys secures Nasdaq extension to regain bid price compliance Seeking Alpha's Quant Rating on Femasys Historical earnings data for Femasys Financial information for Femasys Recommended For You More Trending News
Show less
Read more
Impact Snapshot
Event Time:
FEMY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
FEMY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
FEMY alerts
High impacting Femasys Inc. news events
Weekly update
A roundup of the hottest topics
FEMY
News
- Femasys Launches FemaSeed® Complete for OB/GYNs at ACOG 2026GlobeNewswire
- Femasys Drives International Growth with Israeli Market Entry for Fertility PortfolioGlobeNewswire
- Femasys Appoints John Canning as Chief Operating Officer to Drive Operational Execution and Advance Commercial GrowthGlobeNewswire
- Femasys Announces Financial Results for Year Ended December 31, 2025 and Provides Corporate Update [TheStreet.com]TheStreet.com
- Femasys Announces Financial Results for Year Ended December 31, 2025 and Provides Corporate UpdateGlobeNewswire
FEMY
Sec Filings
- 4/6/26 - Form DEF
- 4/1/26 - Form 4
- 4/1/26 - Form 3
- FEMY's page on the SEC website